EASY BIO,Inc.
353810.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$180.3B
Close$
Share Statistics
| Market cap | $180.30 Billion |
|---|---|
| Enterprise Value | $316.88 Billion |
| Dividend Yield | $250.00 (4.59%) |
| Earnings per Share | $840 |
| Beta | 0.34 |
| Outstanding Shares | 33,082,000 |
Return
| Return on Equity | 31.36% |
|---|---|
| Return on Assets | 10.32% |
| Return on Invested Capital | 16.91% |
Valuation & Multiples
| P/E Ratio | 4.53 |
|---|---|
| PEG | 2.68 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 1.37 |
| Enterprise Value to Revenue | 0.6 |
| Enterprise Value to EBIT | 8.85 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.58 |
| Debt to Equity | 1.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$125.20 B
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$127.70 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About EASY BIO,Inc.
145 employees
CEO: Il-Hwan Hwang Founded in 2020 and headquartered in Seoul, South Korea, EASY BIO, Inc. offers expert solutions, including specialized feed and dietary supplements, for piglets to customers throughout South Korea and on a global scale.